. levy, Md; NaThaN T. ForMaiNi, do; KeviN p. o'doNNell, Md; Molly a. Moor, Mph; leoNardo d. virraroel, bS Anatomic total shoulder arthroplasty (TSA) and reverse total shoulder arthroplasty (RSA) are routinely performed in patients older than 80 years. Often unaware of the differences between the 2 procedures, patients may expect similar outcomes from these procedures. This article reports the outcomes of primary TSA and RSA in patients older than 80 years, with attention directed toward differences in outcomes between the procedures. The authors evaluated a consecutive series of patients who were at least 80 years old and were treated with primary shoulder arthroplasty and had a minimum follow-up of 2 years. Of these patients, 18 underwent primary TSA for osteoarthritis and 33 underwent primary RSA for rotator cuff tear arthropathy. Pain scores, function scores, and range of motion were evaluated preoperatively and at final follow-up. Perioperative and postoperative complications, transfusion rates, length of stay, and subjective satisfaction with the outcome were reported. In these patients, TSA and RSA were similarly effective in improving pain scores, functional scores, and range of motion measurements. Patients who had TSA reported significantly greater satisfaction with surgery and had superior American Shoulder and Elbow Society total and function scores, forward elevation, and external rotation, but similar net improvement from preoperative levels. Although no significant differences were shown in complications, length of stay, or requirement for transfusion, patients treated with RSA had higher rates of transfusion and postoperative complications. Both procedures were similarly effective treatments for patients older than 80 years and showed similar improvements in pain, function, and motion. Patients undergoing RSA were less likely to have good to excellent results, with higher complication and transfusion rates. [Orthopedics. 2015; 38(10):e904-e910.] 
S
houlder arthroplasty is one of the fastest-growing types of joint replacement surgery. [1] [2] [3] Similarly, the fastest-growing segment of the US population is persons older than 80 years. 4 With this segment of the population living longer and expecting greater function and quality of life, shoulder arthroplasty is performed frequently in this patient population. Information on the safety and efficacy of shoulder replacement in the elderly is limited, [5] [6] [7] [8] with a recent Nationwide Implant Sample study suggesting increased rates of in-hospital morbidity and mortality, anemia, and length of stay, in addition to increased cost. 9 Nonetheless, successful outcomes of primary anatomic total shoulder (TSA) and reverse shoulder arthroplasty (RSA) resulted in widespread use in patients older than 80 years. 9 Both TSA and RSA are acceptable options used to treat distinctly different manifestations of end-stage shoulder arthropathy. When treating end-stage glenohumeral arthritis with an intact rotator cuff, TSA showed good long-term function and efficacy in the general population [10] [11] [12] [13] as well as the elderly population. [5] [6] [7] [8] Originally recommended for low-demand patients older than 70 years, RSA has shown reliable results and high patient satisfaction when treating pseudoparesis associated with rotator cuff deficiency and various degrees of arthritis, [14] [15] [16] [17] [18] [19] with indications expanding to include proximal humerus fractures and most arthroplasty revisions. [20] [21] [22] Faced with the decision to undergo shoulder arthroplasty, a patient older than 80 years may be unaware of the differences that can be expected from TSA vs RSA. Patients may expect identical outcomes, even though the pathology being treated is quite different. A few studies showed the success of primary TSA in patients older than 80 years, [5] [6] [7] [8] but no study has evaluated the results of primary RSA in this patient population. A recent study found no difference in outcomes or complications in patients undergoing primary TSA for osteoarthritis and primary RSA for rotator cuff tear arthropathy. 22 However, no study has investigated these differences in this elderly population, where outcomes and complications can be different. This study describes the results of TSA and RSA in patients older than 80 years and compares the outcomes. The authors hypothesized that TSA and RSA show similar levels of safety, outcome scores, and patient satisfaction, with comparable improvements in pain, function, and motion.
Materials and Methods
A retrospective evaluation of prospectively collected data was performed for a consecutive series of patients at least 80 years of age who were treated with primary shoulder arthroplasty. Patients treated with revision shoulder arthroplasty were excluded. Initial review of the Holy Cross Shoulder Outcome Repository identified all potentially eligible patients treated with primary TSA or RSA. Nine patients who died before 2-year follow-up was obtained were excluded. Of the 51 shoulder arthroplasties included, 18 were primary TSA for osteoarthritis and 33 were primary RSA for pseudoparesis associated with variable degrees of rotator cuff tear arthropathy. All patients had a minimum of 2 years of follow-up (average, 39 months; range, 24-87 months). Median patient age was 83.4 years (range, 80-89 years). There was no significant difference in median age between patients treated with TSA (83.9 years) and RSA (82.6 years) (P=.059). The TSA cohort consisted of 8 men and 10 women; the RSA cohort included 13 men and 19 women (1 woman underwent bilateral RSA).
Clinical outcome scores were evaluated preoperatively and at final follow-up to determine the effectiveness of treatment. This was previously defined by Goldberg et al 11 28 and range of motion. At the most recent follow-up, patients were asked to provide their subjective satisfaction with the outcome. All postoperative complications were reported. All hospital records were reviewed to identify perioperative complications, the incidence of transfusion, and length of hospital stay.
Statistical Analysis
Data were analyzed with PASW Statistics version 18 
results
Both TSA and RSA were effective in treating preoperative morbidity. Patients who had RSA showed significant improvements in all pain, function, and range of motion measurements ( Table  1) . Similar improvements in postoperative pain, function, and range of motion occurred in patients who underwent TSA, with the exception of the Simple Shoulder Test score (Table 1) .
Preoperatively, pain and function scores were similar in patients who underwent TSA and RSA. However, preoperative active abduction and elevation were significantly worse in patients who had RSA (P=.007 and P=.001, respectively, Table 2 ).
Postoperatively, patients treated with TSA outperformed those who had RSA ( Table 2) in ASES function score (P=.016), ASES total score (P=.035), active elevation (P=.003), and active external rotation (P=.005). However, direct comparisons between the TSA and RSA groups showed that overall efficacy (change from preoperative to postoperative) was not significantly different for pain, functional outcome score, and range of motion (Table 2 and Figure) .
Perioperative comparison of TSA and RSA is shown in Table 3 . No significant differences were seen in the need for perioperative blood transfusion (P=.231), although patients who had RSA showed a trend toward a higher transfusion rate (21.9% vs 5.6%). No significant differences between the groups were seen in the development of perioperative medical conditions (P=1.0), length of stay (P=.216), or the need for intensive care unit stay (P=1.0) ( Table 3) . Postoperative complication rates were not significantly different between those undergoing TSA and those undergoing RSA (5.6% vs 15.2%, respectively, P=.299). A late complication was reported in the TSA group, a rotator cuff tear at 6 years, with little effect on outcome. Five early complications were observed in the RSA group; these included 2 partial brachial plexopathies and 3 acromion fractures, 1 of which resulted in a subsequent dislocation.
Overall, patients treated with TSA had significantly higher rates of patient satisfaction with the surgical outcome, and 100% of patients who had TSA and 78.8% of those who had RSA rated their outcome as good or excellent (P=.042). Most patients (100% of those who had TSA and 81.1% of those who had RSA) would elect to undergo the same procedure again.
discussion
The results of this study showed that both TSA and RSA are effective treatment options for patients older than 80 years. Although these patient populations have substantially different underlying pathology, the effectiveness of arthroplasty was similar. Comparisons of preoperative and postoperative outcomes (efficacy of treatment) yielded no significant differences between these treatment options in improvement of pain, function, and range of motion (Table 1) .
However, there were differences in the final results of TSA and RSA. Patients treated with TSA significantly outperformed those who required RSA in ASES function score, ASES total score, active elevation, and active external rotation ( Table  2) . Further, significant differences were observed in patient satisfaction (Table 3) , and all patients who underwent TSA rated their outcome as good or excellent and would elect to undergo the same procedure again. Only 78.8% of those who had RSA rated their outcome as good to excel- lent, and only 81.1% said that they would undergo the same procedure again. Both procedures had complication rates comparable to those reported in the literature, but those treated with RSA had higher rates of complications ( Table 3) .
A study contrasted primary TSA and RSA performed for classic indications of glenohumeral osteoarthritis and rota- 
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In a retrospective review of prospectively collected data on 100 primary shoulder arthroplasties (53 RSA procedures and 47 TSA procedures), Kiet et al 22 reported no differences in VAS pain score, ASES function score, ASES total score, forward flexion, abduction, and internal rotation between primary arthroplasty cohorts when evaluating final outcomes. Results of the study, which focused on patients older than 80 years, differed from the current findings. However, in the current study, some final outcomes were similar to those reported by Kiet et al. 22 Patients undergoing TSA who were older than 80 years had significantly higher values for ASES function score, ASES total score, forward flexion, and external rotation. However, when preoperative status was considered in evaluating efficacy (change in outcome from preoperative scores), no significant differences were observed between the TSA and RSA cohorts. Kiet et al 22 did not evaluate efficacy.
Candidates for TSA often differ from those requiring RSA. In addition to having distinctly different pathologic diagnoses, patients requiring RSA had worse preoperative morbidity. Patients undergoing RSA were weaker, with less motion and higher impairment ratings. 29 In the current study of patients older than 80 years, however, both groups were remarkably similar ( Table 2 ). The only significant differences in preoperative morbidity were active abduction and elevation, and patients undergoing RSA showed inferior results. Both groups showed similar improvements in range of motion from baseline, and this finding likely influenced the observed differences in final range of motion between groups ( Table 2) .
Numerous studies showed the ability of anatomic TSA to improve pain and function scores, 4,7,10,13,30,31 but few studies have evaluated these outcomes in the elderly. [5] [6] [7] [8] [9] Foruria et al 6 published 1 of the largest studies (50 shoulders in 44 patients) reporting long-term outcomes of TSA in patients older than 80 years. 6 They concluded that total shoulder replacement is an effective treatment in this cohort, despite the increase in perioperative complications. 6 Churchill 5 investigated the use of TSA in patients older than 90 years and showed significant improvements in range of motion, functional outcomes,
Figure:
Effectiveness of treatment with anatomic total shoulder arthroplasty (TSA) and reverse total shoulder arthroplasty (RSA). No significant differences were found between the cohorts. Abbreviations: ASES, American Shoulder and Elbow Society; Post-op, postoperative; Pre-op, preoperative; SANE, Subjective Assessment Numeric Evaluation; SST, Simple Shoulder Test; VAS, visual analog scale. Numerous studies showed good results and high patient satisfaction after RSA. [14] [15] [16] [17] [18] [19] 32 However, no study has evaluated the results in patients older than 80 years. The current results suggested that RSA is an effective treatment in patients older than 80 years, with significant improvements from preoperatively measured outcome scores, pain scores, and range of motion. Although the complication rate observed was comparable to previous reports, [14] [15] [16] [17] [18] [19] 32 the complications were clinically significant and likely affected outcome. Postoperative acromion fractures, observed in 3 patients, have been shown to influence the functional result of RSA 33, 34 and can even result in dislocation, 35 as seen in 1 patient. Partial brachial plexopathies, seen in 2 patients, have been reported at a higher prevalence in RSA. 36 These complications were unique to the RSA group and were not seen in any patients treated with TSA.
Postoperative anemia and increased transfusion rates were higher in patients older than 80 years. 8, 9 This was certainly true for patients treated with RSA in this study, with a transfusion rate of 22%. However, for patients undergoing TSA, only 1 patient required a transfusion. Although no statistically significant difference was observed between TSA and RSA, this finding likely was related to the low number of transfusions required in this study. The increased rate of transfusion in the RSA group could be explained in part by the increased dead space present in the enlarged subacromial space devoid of soft tissue seen in patients undergoing RSA.
In the current study, all patients treated with RSA had preoperative rotator cuff dysfunction and pseudoparalysis. There has been recent consideration of the use of RSA in patients older than 80 years with osteoarthritis and an intact rotator cuff. Elderly patients often have advanced shoulder wear patterns, especially about the glenoid, which may preclude safe and stable implantation of a polyethylene glenoid component. These glenoid deformities may be more easily managed with RSA than with TSA. In the only published series using RSA for osteoarthritis in patients with an intact rotator cuff, Mizuno et al 37 described excellent clinical outcomes in patients with severely posteriorly eroded glenoids and static posterior subluxation. Additionally, it is reasonable to have concern about the integrity of the rotator cuff in elderly patients undergoing TSA. After all, rotator cuff degeneration and secondary superior humeral migration have been reported in the elderly after TSA. 6, 38 A 17% prevalence of rotator cuff dysfunction was reported after TSA at an average of 104 months, resulting in significantly lower clinical outcomes compared with patients with an intact rotator cuff. 39 Nonetheless, there is no evidence to suggest that RSA outperforms TSA in patients with end-stage glenohumeral arthritis and an intact rotator cuff. Further study of the role of RSA in treating glenohumeral arthritis in patients older than 80 years with an intact rotator cuff is warranted. Based on the results of this study, specific attention should be directed at differences in patient satisfaction and clinically significant complication rates compared with the results of TSA in this patient population.
Limitations
This study had several limitations. First, a single surgeon at a single institution performed all primary shoulder arthroplasties. Postoperative results may differ with variations in technique, learning curve, and implant selection. Second, nearly twice as many RSA procedures as TSA procedures were performed. This likely affected the ability to observe significant differences in several measures, such as complication and transfusion rates. Larger cohorts or multicenter studies will help to better examine these differences in this patient population. Despite the limited 2-year follow-up data in this patient cohort, this study was inadequately powered. Finally, a conclusion could not be drawn about the universal use of RSA in patients older than 80 years because the study maintained strict indications involving rotator cuff dysfunction and pseudoparesis. A randomized trial comparing TSA and RSA in patients with intact rotator cuffs is needed to answer this question. This study compared the results of TSA and RSA with currently accepted operative indications in similar groups of patients older than 80 years and showed similar efficacy of both procedures.
conclusion
Both TSA and RSA are effective treatments for patients older than 80 years, with similar improvements in pain scores, functional outcome scores, and range of motion after 2 years of follow-up. Those treated with RSA showed significantly less postoperative motion, lower satisfaction with the outcome, and higher complication and transfusion rates.
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